WHITEHAWK THERAPEUTICS, INC. Restructuring Costs
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Restructuring Costs of $1.24 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2021-08-11
- WHITEHAWK THERAPEUTICS, INC. restructuring costs for the quarter ending 2021-06-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. restructuring costs for the quarter ending 2021-03-31 was $1.24M.
- WHITEHAWK THERAPEUTICS, INC. restructuring costs for the quarter ending 2019-12-31 was $987.21K.
- WHITEHAWK THERAPEUTICS, INC. restructuring costs for the quarter ending 2019-09-30 was -$38.81K.
- WHITEHAWK THERAPEUTICS, INC. restructuring costs for fiscal 2019 was $1.86M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.24M 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | $1.24M 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $987.21K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $948.40K derived: sum of 2 quarters · filed 2021-03-11 | $1.86M derived: sum of 3 quarters · filed 2021-03-11 | $1.86M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$38.81K 10-Q · filed 2020-11-10 | $876.28K derived: sum of 2 quarters · filed 2020-11-10 | $876.28K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $915.09K 10-Q · filed 2020-08-12 | $915.09K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |